IBC’s 3rd European Conference Assay Development 2004, Amsterdam, The Netherlands
Event Nov 03
This 2-day conference will provide a thorough update on cellular, biochemical and functional assays, including the hottest issues in assay design and analysis, high-throughput screening and optimisation of techniques, to enable study of difficult target classes. Hear real-life case studies from Eli Lilly, Cambridge Antibody, Merck, Sharp & Dohme and Boehringer Ingelheim, explaining how they harnessed the latest technology, implemented successful screening strategies, overcame the challenges and benefited from high content screening.
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018